

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phenol-containing compound catabolic process (GO:0019336) | 9.92088808 |
| 2 | catecholamine transport (GO:0051937) | 9.05549379 |
| 3 | * catecholamine biosynthetic process (GO:0042423) | 7.48773434 |
| 4 | * catechol-containing compound biosynthetic process (GO:0009713) | 7.48773434 |
| 5 | neurotransmitter catabolic process (GO:0042135) | 7.04242470 |
| 6 | regulation of catecholamine metabolic process (GO:0042069) | 6.51554645 |
| 7 | regulation of dopamine metabolic process (GO:0042053) | 6.51554645 |
| 8 | * dopamine metabolic process (GO:0042417) | 6.06029548 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 5.88964603 |
| 10 | * alkaloid metabolic process (GO:0009820) | 5.83512774 |
| 11 | monoamine transport (GO:0015844) | 5.53171724 |
| 12 | * neurotransmitter biosynthetic process (GO:0042136) | 5.40807811 |
| 13 | prepulse inhibition (GO:0060134) | 5.32281277 |
| 14 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.30359604 |
| 15 | synaptic transmission, cholinergic (GO:0007271) | 5.25749804 |
| 16 | enteric nervous system development (GO:0048484) | 5.18710885 |
| 17 | glutamate secretion (GO:0014047) | 5.13512079 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 5.08161963 |
| 19 | negative regulation of microtubule polymerization (GO:0031115) | 5.04906738 |
| 20 | regulation of dopamine secretion (GO:0014059) | 5.03969384 |
| 21 | negative regulation of neurotransmitter transport (GO:0051589) | 4.70697786 |
| 22 | behavioral response to nicotine (GO:0035095) | 4.66614652 |
| 23 | response to cocaine (GO:0042220) | 4.66526601 |
| 24 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.65545588 |
| 25 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.65545588 |
| 26 | auditory behavior (GO:0031223) | 4.64571373 |
| 27 | neurofilament cytoskeleton organization (GO:0060052) | 4.53317731 |
| 28 | behavioral response to cocaine (GO:0048148) | 4.52649966 |
| 29 | * phenol-containing compound biosynthetic process (GO:0046189) | 4.50222045 |
| 30 | * response to insecticide (GO:0017085) | 4.49311400 |
| 31 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.47257037 |
| 32 | positive regulation of glomerulus development (GO:0090193) | 4.32738036 |
| 33 | positive regulation of cell size (GO:0045793) | 4.29581485 |
| 34 | protein localization to synapse (GO:0035418) | 4.26839347 |
| 35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.24117589 |
| 36 | * catecholamine metabolic process (GO:0006584) | 4.22193242 |
| 37 | * catechol-containing compound metabolic process (GO:0009712) | 4.22193242 |
| 38 | establishment of mitochondrion localization (GO:0051654) | 4.18062294 |
| 39 | behavioral response to ethanol (GO:0048149) | 4.14503117 |
| 40 | nucleobase catabolic process (GO:0046113) | 4.07979635 |
| 41 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.01902894 |
| 42 | * neurotransmitter metabolic process (GO:0042133) | 4.01136993 |
| 43 | regulation of oxidative phosphorylation (GO:0002082) | 4.00354215 |
| 44 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.96436702 |
| 45 | mitochondrion transport along microtubule (GO:0047497) | 3.96436702 |
| 46 | synapse assembly (GO:0007416) | 3.93963756 |
| 47 | neuron recognition (GO:0008038) | 3.78328535 |
| 48 | neurotransmitter secretion (GO:0007269) | 3.75003755 |
| 49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.73969693 |
| 50 | neurotransmitter transport (GO:0006836) | 3.70258628 |
| 51 | * regulation of neurotransmitter levels (GO:0001505) | 3.68174791 |
| 52 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.67410599 |
| 53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.66311292 |
| 54 | neuronal action potential (GO:0019228) | 3.62104164 |
| 55 | * toxin metabolic process (GO:0009404) | 3.60557685 |
| 56 | synaptic vesicle maturation (GO:0016188) | 3.60113304 |
| 57 | regulation of vesicle fusion (GO:0031338) | 3.52420592 |
| 58 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.51760972 |
| 59 | response to auditory stimulus (GO:0010996) | 3.50462939 |
| 60 | axonal fasciculation (GO:0007413) | 3.47352691 |
| 61 | positive regulation of vesicle fusion (GO:0031340) | 3.46897043 |
| 62 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.46280794 |
| 63 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.46280794 |
| 64 | response to pain (GO:0048265) | 3.45001726 |
| 65 | * synaptic transmission, dopaminergic (GO:0001963) | 3.44745870 |
| 66 | neuromuscular synaptic transmission (GO:0007274) | 3.41440905 |
| 67 | synaptic transmission, glutamatergic (GO:0035249) | 3.40670671 |
| 68 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.40579161 |
| 69 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.39315233 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.37243308 |
| 71 | opioid receptor signaling pathway (GO:0038003) | 3.35335291 |
| 72 | innervation (GO:0060384) | 3.34866134 |
| 73 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.34571641 |
| 74 | mechanosensory behavior (GO:0007638) | 3.34559364 |
| 75 | primary amino compound metabolic process (GO:1901160) | 3.31995932 |
| 76 | * establishment of synaptic vesicle localization (GO:0097480) | 3.31136970 |
| 77 | * synaptic vesicle transport (GO:0048489) | 3.31136970 |
| 78 | * response to nicotine (GO:0035094) | 3.29680425 |
| 79 | serotonin metabolic process (GO:0042428) | 3.29409797 |
| 80 | neuron maturation (GO:0042551) | 3.25613899 |
| 81 | regulation of receptor recycling (GO:0001919) | 3.24923972 |
| 82 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.24847657 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23396477 |
| 84 | membrane depolarization during action potential (GO:0086010) | 3.20681878 |
| 85 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.18195277 |
| 86 | negative regulation of membrane potential (GO:0045837) | 3.16635017 |
| 87 | dendritic spine morphogenesis (GO:0060997) | 3.16081194 |
| 88 | regulation of catecholamine secretion (GO:0050433) | 3.15784155 |
| 89 | regulation of neurotransmitter uptake (GO:0051580) | 3.15366874 |
| 90 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.13534932 |
| 91 | cerebellar Purkinje cell layer development (GO:0021680) | 3.12697675 |
| 92 | electron transport chain (GO:0022900) | 3.12619078 |
| 93 | positive regulation of synapse assembly (GO:0051965) | 3.11909098 |
| 94 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11416670 |
| 95 | negative regulation of catecholamine secretion (GO:0033604) | 3.11188768 |
| 96 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.08296256 |
| 97 | ATP synthesis coupled proton transport (GO:0015986) | 3.08296256 |
| 98 | respiratory electron transport chain (GO:0022904) | 3.08106254 |
| 99 | dendrite morphogenesis (GO:0048813) | 3.07365011 |
| 100 | transferrin transport (GO:0033572) | 3.07311278 |
| 101 | striatum development (GO:0021756) | 3.07178054 |
| 102 | response to iron ion (GO:0010039) | 3.04235310 |
| 103 | regulation of protein kinase A signaling (GO:0010738) | 3.02035160 |
| 104 | dopaminergic neuron differentiation (GO:0071542) | 3.01855571 |
| 105 | regulation of cell maturation (GO:1903429) | 3.01637481 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 2.98354562 |
| 107 | glutamate receptor signaling pathway (GO:0007215) | 2.98318977 |
| 108 | positive regulation of response to oxidative stress (GO:1902884) | 2.96331672 |
| 109 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.96331672 |
| 110 | synaptic vesicle endocytosis (GO:0048488) | 2.95436731 |
| 111 | vocalization behavior (GO:0071625) | 2.94551093 |
| 112 | negative regulation of amine transport (GO:0051953) | 2.93576009 |
| 113 | regulation of collateral sprouting (GO:0048670) | 2.92025714 |
| 114 | * neuron-neuron synaptic transmission (GO:0007270) | 2.91978495 |
| 115 | membrane depolarization (GO:0051899) | 2.91486703 |
| 116 | * response to amphetamine (GO:0001975) | 2.90960546 |
| 117 | synapse organization (GO:0050808) | 2.89392133 |
| 118 | regulation of synaptic vesicle transport (GO:1902803) | 2.88813926 |
| 119 | proline transport (GO:0015824) | 2.87948342 |
| 120 | exploration behavior (GO:0035640) | 2.87359505 |
| 121 | ferric iron transport (GO:0015682) | 2.87084813 |
| 122 | trivalent inorganic cation transport (GO:0072512) | 2.87084813 |
| 123 | regulation of glomerulus development (GO:0090192) | 2.86843495 |
| 124 | cellular response to epinephrine stimulus (GO:0071872) | 2.86824996 |
| 125 | positive regulation of growth hormone secretion (GO:0060124) | 2.86797397 |
| 126 | regulation of neurotransmitter transport (GO:0051588) | 2.85141403 |
| 127 | gamma-aminobutyric acid transport (GO:0015812) | 2.84911683 |
| 128 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84059022 |
| 129 | inositol phosphate catabolic process (GO:0071545) | 2.83942613 |
| 130 | cell migration in hindbrain (GO:0021535) | 2.83850142 |
| 131 | axon extension (GO:0048675) | 2.82943790 |
| 132 | inositol phosphate dephosphorylation (GO:0046855) | 2.81706786 |
| 133 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.81706786 |
| 134 | response to ammonium ion (GO:0060359) | 2.80839496 |
| 135 | dendrite development (GO:0016358) | 2.80714442 |
| 136 | apical protein localization (GO:0045176) | 2.80252881 |
| 137 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.79553708 |
| 138 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.78921531 |
| 139 | postsynaptic membrane organization (GO:0001941) | 2.78009467 |
| 140 | protein localization to cilium (GO:0061512) | 2.77381869 |
| 141 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.76587927 |
| 142 | adult walking behavior (GO:0007628) | 2.73607712 |
| 143 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.73082765 |
| 144 | regulation of postsynaptic membrane potential (GO:0060078) | 2.71637873 |
| 145 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65916103 |
| 146 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.63116439 |
| 147 | sex differentiation (GO:0007548) | 2.62448796 |
| 148 | response to histamine (GO:0034776) | 2.61952789 |
| 149 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.61312827 |
| 150 | positive regulation of multicellular organism growth (GO:0040018) | 2.61239278 |
| 151 | short-term memory (GO:0007614) | 2.58558417 |
| 152 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.56695185 |
| 153 | dopamine transport (GO:0015872) | 11.5882901 |
| 154 | * dopamine biosynthetic process (GO:0042416) | 10.9708229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.38044505 |
| 2 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.87663463 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.28943821 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27180841 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14413835 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13560493 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.00198495 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.87369903 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64761636 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.63556246 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.63210828 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59717331 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53833225 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.52812684 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45041373 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.43354800 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42917962 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42270303 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42270303 |
| 20 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.41504333 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40865662 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38389182 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.26682269 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25325447 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21667585 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.20050935 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16657488 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09453649 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.08117961 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.98270737 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.96557394 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94330104 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90989308 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88966237 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85387026 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81919922 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79836025 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.79523025 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76280895 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71092976 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67398059 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65037693 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63102496 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60440503 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59859472 |
| 46 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.50420830 |
| 47 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.49137466 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46128271 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45971255 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43240747 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40747047 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38771078 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28812766 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28571403 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28072433 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27135782 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25186214 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24830829 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23534910 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21676743 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21090636 |
| 62 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21038373 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21028919 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20960935 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19162493 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11393440 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10026813 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09893401 |
| 69 | JUN_21703547_ChIP-Seq_K562_Human | 1.09320302 |
| 70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09065501 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09037271 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08690122 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08690122 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07126071 |
| 75 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05812117 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99555872 |
| 77 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98794105 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98487528 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97120515 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97120515 |
| 81 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.96455958 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96315887 |
| 83 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95979209 |
| 84 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94379780 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.93835492 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93228293 |
| 87 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.92940958 |
| 88 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92598215 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 0.92425615 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92420168 |
| 91 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92208528 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92039720 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91577006 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91314842 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91211714 |
| 96 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91060226 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91058307 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90505706 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89891349 |
| 100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89771993 |
| 101 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89649098 |
| 102 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.89161245 |
| 103 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.88277324 |
| 104 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87772391 |
| 105 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.86963137 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86922061 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86527674 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86489492 |
| 109 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86405995 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85963497 |
| 111 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84608489 |
| 112 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84608489 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82653091 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82289270 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81117170 |
| 116 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80246924 |
| 117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.79949570 |
| 118 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.79418624 |
| 119 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79015170 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78604012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001905_abnormal_dopamine_level | 5.09445368 |
| 2 | MP0002822_catalepsy | 4.91555050 |
| 3 | MP0001529_abnormal_vocalization | 4.78194227 |
| 4 | MP0003880_abnormal_central_pattern | 4.30116620 |
| 5 | MP0006276_abnormal_autonomic_nervous | 4.23122402 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.23115698 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.80688303 |
| 8 | MP0003122_maternal_imprinting | 2.77418633 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.76772538 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.72968573 |
| 11 | MP0002733_abnormal_thermal_nociception | 2.69929824 |
| 12 | MP0005386_behavior/neurological_phenoty | 2.46227127 |
| 13 | MP0004924_abnormal_behavior | 2.46227127 |
| 14 | MP0009745_abnormal_behavioral_response | 2.43082841 |
| 15 | MP0002064_seizures | 2.40294563 |
| 16 | MP0002102_abnormal_ear_morphology | 2.39625098 |
| 17 | MP0009046_muscle_twitch | 2.36873867 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.36866125 |
| 19 | MP0008872_abnormal_physiological_respon | 2.34120881 |
| 20 | MP0001970_abnormal_pain_threshold | 2.27392652 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.22650309 |
| 22 | MP0003121_genomic_imprinting | 2.16020497 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.12629599 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.10064691 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.09377774 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.08360779 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.07339318 |
| 28 | MP0003787_abnormal_imprinting | 2.07163842 |
| 29 | MP0004270_analgesia | 2.05011363 |
| 30 | MP0002751_abnormal_autonomic_nervous | 2.03330770 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.97952803 |
| 32 | MP0001188_hyperpigmentation | 1.96900639 |
| 33 | MP0002184_abnormal_innervation | 1.88498301 |
| 34 | MP0002736_abnormal_nociception_after | 1.86277943 |
| 35 | * MP0002063_abnormal_learning/memory/cond | 1.82337564 |
| 36 | MP0001664_abnormal_digestion | 1.76282059 |
| 37 | MP0002272_abnormal_nervous_system | 1.73870360 |
| 38 | MP0005409_darkened_coat_color | 1.71083748 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.69006745 |
| 40 | MP0005535_abnormal_body_temperature | 1.68528589 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.67664624 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.64742879 |
| 43 | MP0001486_abnormal_startle_reflex | 1.61978954 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.56242974 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.51846909 |
| 46 | MP0000639_abnormal_adrenal_gland | 1.51764106 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.46816235 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.45591595 |
| 49 | MP0003868_abnormal_feces_composition | 1.43429990 |
| 50 | MP0008995_early_reproductive_senescence | 1.40176050 |
| 51 | MP0004133_heterotaxia | 1.30725636 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.29953790 |
| 53 | MP0004858_abnormal_nervous_system | 1.26792713 |
| 54 | MP0000955_abnormal_spinal_cord | 1.25863988 |
| 55 | MP0000751_myopathy | 1.22242153 |
| 56 | MP0004885_abnormal_endolymph | 1.22232976 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.18331921 |
| 58 | MP0000747_muscle_weakness | 1.18219554 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.15421658 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.12935062 |
| 61 | MP0002090_abnormal_vision | 1.11967094 |
| 62 | MP0000566_synostosis | 1.11837929 |
| 63 | MP0002163_abnormal_gland_morphology | 1.11300750 |
| 64 | MP0005379_endocrine/exocrine_gland_phen | 1.09589029 |
| 65 | MP0000778_abnormal_nervous_system | 1.07928311 |
| 66 | MP0001270_distended_abdomen | 1.03583649 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.98853892 |
| 68 | MP0000569_abnormal_digit_pigmentation | 0.98159013 |
| 69 | MP0002882_abnormal_neuron_morphology | 0.97724027 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.97068317 |
| 71 | MP0001984_abnormal_olfaction | 0.96673907 |
| 72 | MP0003329_amyloid_beta_deposits | 0.94105434 |
| 73 | MP0004142_abnormal_muscle_tone | 0.93984463 |
| 74 | MP0003632_abnormal_nervous_system | 0.90296117 |
| 75 | MP0005248_abnormal_Harderian_gland | 0.90029694 |
| 76 | MP0003866_abnormal_defecation | 0.90012463 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.89329253 |
| 78 | MP0005253_abnormal_eye_physiology | 0.89247080 |
| 79 | MP0000026_abnormal_inner_ear | 0.86997318 |
| 80 | MP0008874_decreased_physiological_sensi | 0.86878024 |
| 81 | MP0008569_lethality_at_weaning | 0.84336631 |
| 82 | MP0005187_abnormal_penis_morphology | 0.84075378 |
| 83 | MP0000049_abnormal_middle_ear | 0.83574199 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 0.82451858 |
| 85 | MP0003631_nervous_system_phenotype | 0.79768857 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.79735275 |
| 87 | MP0005171_absent_coat_pigmentation | 0.78372465 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.78114791 |
| 89 | MP0000534_abnormal_ureter_morphology | 0.77820243 |
| 90 | MP0003315_abnormal_perineum_morphology | 0.76556757 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 0.74683501 |
| 92 | MP0003861_abnormal_nervous_system | 0.72709125 |
| 93 | MP0004085_abnormal_heartbeat | 0.72191119 |
| 94 | MP0004742_abnormal_vestibular_system | 0.72138586 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.72009001 |
| 96 | MP0004883_abnormal_blood_vessel | 0.70182087 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.69813266 |
| 98 | MP0001881_abnormal_mammary_gland | 0.68878882 |
| 99 | MP0002229_neurodegeneration | 0.67956177 |
| 100 | MP0003879_abnormal_hair_cell | 0.65793024 |
| 101 | MP0009379_abnormal_foot_pigmentation | 0.65684407 |
| 102 | MP0002152_abnormal_brain_morphology | 0.64713948 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.64082760 |
| 104 | MP0003942_abnormal_urinary_system | 0.63779915 |
| 105 | MP0005083_abnormal_biliary_tract | 0.63235420 |
| 106 | MP0001324_abnormal_eye_pigmentation | 0.62681352 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.62557520 |
| 108 | MP0005195_abnormal_posterior_eye | 0.62190535 |
| 109 | MP0001340_abnormal_eyelid_morphology | 0.61813878 |
| 110 | MP0005499_abnormal_olfactory_system | 0.61523691 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.61523691 |
| 112 | MP0000427_abnormal_hair_cycle | 0.61048288 |
| 113 | MP0002082_postnatal_lethality | 0.59804853 |
| 114 | MP0010770_preweaning_lethality | 0.59804853 |
| 115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.59781783 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 0.59593025 |
| 117 | MP0003633_abnormal_nervous_system | 0.59498617 |
| 118 | MP0003011_delayed_dark_adaptation | 0.58957365 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.58754747 |
| 120 | MP0002752_abnormal_somatic_nervous | 0.57317845 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.54994659 |
| 122 | MP0005310_abnormal_salivary_gland | 0.54387046 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.53973742 |
| 124 | MP0003634_abnormal_glial_cell | 0.52464823 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.51787250 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.51743944 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.49503425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 8.87298431 |
| 2 | Pheochromocytoma (HP:0002666) | 7.41009368 |
| 3 | Neuroendocrine neoplasm (HP:0100634) | 6.79494578 |
| 4 | Failure to thrive in infancy (HP:0001531) | 5.75437596 |
| 5 | Visual hallucinations (HP:0002367) | 5.57819679 |
| 6 | Potter facies (HP:0002009) | 5.29477363 |
| 7 | Facial shape deformation (HP:0011334) | 5.29477363 |
| 8 | Abnormal pupillary function (HP:0007686) | 4.79525794 |
| 9 | Akinesia (HP:0002304) | 4.60737594 |
| 10 | Myokymia (HP:0002411) | 4.60704616 |
| 11 | Hypoventilation (HP:0002791) | 4.46378186 |
| 12 | Cerebral hemorrhage (HP:0001342) | 4.27457067 |
| 13 | Hypercortisolism (HP:0001578) | 4.18881478 |
| 14 | Orthostatic hypotension (HP:0001278) | 4.12529927 |
| 15 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.09190495 |
| 16 | Abnormality of the parathyroid morphology (HP:0011766) | 3.82844836 |
| 17 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.66439344 |
| 18 | Postural instability (HP:0002172) | 3.63280064 |
| 19 | Limb hypertonia (HP:0002509) | 3.46734193 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.44016451 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 3.43388349 |
| 22 | Postural tremor (HP:0002174) | 3.43211481 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 3.33214012 |
| 24 | Delayed gross motor development (HP:0002194) | 3.32722260 |
| 25 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.28984779 |
| 26 | Focal seizures (HP:0007359) | 3.27326208 |
| 27 | Drooling (HP:0002307) | 3.05507749 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.03257857 |
| 29 | Retinal dysplasia (HP:0007973) | 3.01506707 |
| 30 | Mitochondrial inheritance (HP:0001427) | 2.97792952 |
| 31 | Focal motor seizures (HP:0011153) | 2.97169219 |
| 32 | Hypsarrhythmia (HP:0002521) | 2.95574973 |
| 33 | EEG with generalized epileptiform discharges (HP:0011198) | 2.93294064 |
| 34 | Thyroid carcinoma (HP:0002890) | 2.92057754 |
| 35 | Gait imbalance (HP:0002141) | 2.90225498 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.89221555 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 2.87421366 |
| 38 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.85186942 |
| 39 | Agitation (HP:0000713) | 2.82635558 |
| 40 | Hyperparathyroidism (HP:0000843) | 2.82504666 |
| 41 | Excessive salivation (HP:0003781) | 2.80408072 |
| 42 | Hypotension (HP:0002615) | 2.79755860 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.71668975 |
| 44 | Amyotrophic lateral sclerosis (HP:0007354) | 2.68265481 |
| 45 | Primitive neuroectodermal tumor (HP:0030065) | 2.65662595 |
| 46 | Neuroblastic tumors (HP:0004376) | 2.65662595 |
| 47 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.65662595 |
| 48 | Neuroblastoma (HP:0003006) | 2.65662595 |
| 49 | Genital tract atresia (HP:0001827) | 2.64837524 |
| 50 | Insidious onset (HP:0003587) | 2.63086000 |
| 51 | Termporal pattern (HP:0011008) | 2.63086000 |
| 52 | Mutism (HP:0002300) | 2.61729038 |
| 53 | Acute encephalopathy (HP:0006846) | 2.60693416 |
| 54 | Dysautonomia (HP:0002459) | 2.59548744 |
| 55 | Action tremor (HP:0002345) | 2.58694221 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57652193 |
| 57 | Vaginal atresia (HP:0000148) | 2.54661112 |
| 58 | Generalized tonic-clonic seizures (HP:0002069) | 2.54043527 |
| 59 | Delusions (HP:0000746) | 2.53702903 |
| 60 | Anxiety (HP:0000739) | 2.52109208 |
| 61 | * Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46172152 |
| 62 | Emotional lability (HP:0000712) | 2.44327956 |
| 63 | Dyskinesia (HP:0100660) | 2.43235890 |
| 64 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.41858689 |
| 65 | Progressive inability to walk (HP:0002505) | 2.41619851 |
| 66 | Myotonia (HP:0002486) | 2.41604121 |
| 67 | Hepatocellular necrosis (HP:0001404) | 2.40952125 |
| 68 | * Diminished movement (HP:0002374) | 2.38411721 |
| 69 | Ulnar claw (HP:0001178) | 2.37498349 |
| 70 | Status epilepticus (HP:0002133) | 2.35513316 |
| 71 | Bradykinesia (HP:0002067) | 2.35389265 |
| 72 | Bicornuate uterus (HP:0000813) | 2.32228684 |
| 73 | Increased CSF lactate (HP:0002490) | 2.29849570 |
| 74 | Inability to walk (HP:0002540) | 2.29055912 |
| 75 | Atonic seizures (HP:0010819) | 2.28018164 |
| 76 | Adrenal overactivity (HP:0002717) | 2.27741984 |
| 77 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.27257068 |
| 78 | Hypoplasia of the brainstem (HP:0002365) | 2.27257068 |
| 79 | Absence seizures (HP:0002121) | 2.26672352 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.23072187 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.23072187 |
| 82 | Acute lymphatic leukemia (HP:0006721) | 2.22265616 |
| 83 | * Rigidity (HP:0002063) | 2.21548716 |
| 84 | Amblyopia (HP:0000646) | 2.18744759 |
| 85 | * Muscular hypotonia of the trunk (HP:0008936) | 2.18565321 |
| 86 | Torticollis (HP:0000473) | 2.15430630 |
| 87 | Truncal ataxia (HP:0002078) | 2.13840805 |
| 88 | Broad-based gait (HP:0002136) | 2.13624054 |
| 89 | Cholecystitis (HP:0001082) | 2.13020349 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.13020349 |
| 91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.12211879 |
| 92 | Poor suck (HP:0002033) | 2.10619561 |
| 93 | Craniofacial dystonia (HP:0012179) | 2.10179375 |
| 94 | Lissencephaly (HP:0001339) | 2.08522649 |
| 95 | Supranuclear gaze palsy (HP:0000605) | 2.08318979 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 2.07978937 |
| 97 | Generalized myoclonic seizures (HP:0002123) | 2.07856806 |
| 98 | Depression (HP:0000716) | 2.07689496 |
| 99 | Type II lissencephaly (HP:0007260) | 2.07109506 |
| 100 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.07076045 |
| 101 | Febrile seizures (HP:0002373) | 2.05581566 |
| 102 | Congenital primary aphakia (HP:0007707) | 2.05463590 |
| 103 | Fetal akinesia sequence (HP:0001989) | 2.04989593 |
| 104 | Dialeptic seizures (HP:0011146) | 2.02026675 |
| 105 | Nephronophthisis (HP:0000090) | 2.00939860 |
| 106 | Goiter (HP:0000853) | 2.00537878 |
| 107 | Spastic tetraplegia (HP:0002510) | 2.00245499 |
| 108 | * Limb dystonia (HP:0002451) | 10.4196062 |
| 109 | Poor eye contact (HP:0000817) | 1.98938795 |
| 110 | Polyphagia (HP:0002591) | 1.98006686 |
| 111 | Abnormality of pain sensation (HP:0010832) | 1.97495106 |
| 112 | Impaired pain sensation (HP:0007328) | 1.97495106 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97393924 |
| 114 | Focal dystonia (HP:0004373) | 1.94906526 |
| 115 | Cortical dysplasia (HP:0002539) | 1.94820377 |
| 116 | Esotropia (HP:0000565) | 1.93689737 |
| 117 | Abnormality of the corticospinal tract (HP:0002492) | 1.91342828 |
| 118 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91258156 |
| 119 | Rapidly progressive (HP:0003678) | 1.90836861 |
| 120 | Abnormality of the vocal cords (HP:0008777) | 1.88773423 |
| 121 | Anosmia (HP:0000458) | 1.86083219 |
| 122 | Exotropia (HP:0000577) | 1.85923474 |
| 123 | Oligomenorrhea (HP:0000876) | 1.85007936 |
| 124 | Increased hepatocellular lipid droplets (HP:0006565) | 1.84685838 |
| 125 | Cerebral edema (HP:0002181) | 1.83533274 |
| 126 | Psychosis (HP:0000709) | 1.80966169 |
| 127 | Abnormal hair whorl (HP:0010721) | 1.80958856 |
| 128 | Hepatic necrosis (HP:0002605) | 1.80154958 |
| 129 | Gastroesophageal reflux (HP:0002020) | 1.79686060 |
| 130 | Optic disc pallor (HP:0000543) | 1.79059171 |
| 131 | Renal Fanconi syndrome (HP:0001994) | 1.76980352 |
| 132 | Impaired social interactions (HP:0000735) | 1.76562903 |
| 133 | Abnormal social behavior (HP:0012433) | 1.76562903 |
| 134 | Neonatal onset (HP:0003623) | 1.75953308 |
| 135 | Oligodactyly (hands) (HP:0001180) | 1.74564631 |
| 136 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73524639 |
| 137 | Abnormality of salivation (HP:0100755) | 1.72272523 |
| 138 | Epileptic encephalopathy (HP:0200134) | 1.72182779 |
| 139 | Chronic hepatic failure (HP:0100626) | 1.72070457 |
| 140 | Specific learning disability (HP:0001328) | 1.71679783 |
| 141 | Hemiparesis (HP:0001269) | 1.69619597 |
| 142 | Abnormal eating behavior (HP:0100738) | 1.68535555 |
| 143 | Disproportionate tall stature (HP:0001519) | 1.67191142 |
| 144 | * Hypokinesia (HP:0002375) | 1.67002076 |
| 145 | * Myoclonus (HP:0001336) | 1.66734414 |
| 146 | Intestinal atresia (HP:0011100) | 1.66589185 |
| 147 | Ankle clonus (HP:0011448) | 1.66472327 |
| 148 | Labial hypoplasia (HP:0000066) | 1.66421813 |
| 149 | Sleep apnea (HP:0010535) | 1.63822567 |
| 150 | Genetic anticipation (HP:0003743) | 1.63449436 |
| 151 | Urinary urgency (HP:0000012) | 1.63391740 |
| 152 | Ventricular fibrillation (HP:0001663) | 1.63390216 |
| 153 | Neurofibrillary tangles (HP:0002185) | 1.63253635 |
| 154 | Restlessness (HP:0000711) | 1.62763749 |
| 155 | Testicular neoplasm (HP:0010788) | 1.62562417 |
| 156 | Renal dysplasia (HP:0000110) | 1.62326214 |
| 157 | Leukodystrophy (HP:0002415) | 1.61126728 |
| 158 | Pancreatic fibrosis (HP:0100732) | 1.60994077 |
| 159 | Diplopia (HP:0000651) | 1.60823480 |
| 160 | Abnormality of binocular vision (HP:0011514) | 1.60823480 |
| 161 | Hyperaldosteronism (HP:0000859) | 1.60552888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 4.70440044 |
| 2 | MAP3K12 | 4.52479207 |
| 3 | BUB1 | 3.60284670 |
| 4 | CSNK1G3 | 3.21676082 |
| 5 | NTRK1 | 3.16585055 |
| 6 | PNCK | 3.08657815 |
| 7 | PINK1 | 3.08276518 |
| 8 | GRK6 | 3.07408396 |
| 9 | CSNK1G2 | 2.92283131 |
| 10 | ARAF | 2.89608828 |
| 11 | MAP3K9 | 2.87867484 |
| 12 | ADRBK2 | 2.49380152 |
| 13 | PLK2 | 2.48454461 |
| 14 | MAP3K4 | 2.38672368 |
| 15 | CSNK1G1 | 2.32922375 |
| 16 | BCKDK | 2.31737324 |
| 17 | RET | 2.26724921 |
| 18 | MINK1 | 2.19754688 |
| 19 | MAP2K4 | 2.09849577 |
| 20 | NTRK3 | 2.05873900 |
| 21 | DYRK2 | 2.05189442 |
| 22 | PTK2B | 2.01541535 |
| 23 | FGR | 1.92260468 |
| 24 | WNK4 | 1.91840823 |
| 25 | MAP2K7 | 1.86115758 |
| 26 | LATS2 | 1.82512606 |
| 27 | STK39 | 1.78817574 |
| 28 | GRK7 | 1.62665281 |
| 29 | KSR2 | 1.62093184 |
| 30 | UHMK1 | 1.52276701 |
| 31 | TSSK6 | 1.49230833 |
| 32 | PTK2 | 1.40834771 |
| 33 | NTRK2 | 1.35418373 |
| 34 | MARK1 | 1.33482004 |
| 35 | MAP4K2 | 1.30219046 |
| 36 | NME1 | 1.27661432 |
| 37 | ADRBK1 | 1.26443359 |
| 38 | AKT3 | 1.18125479 |
| 39 | TNIK | 1.12924515 |
| 40 | CASK | 1.08549167 |
| 41 | ERBB3 | 1.07112386 |
| 42 | BMPR1B | 1.06363722 |
| 43 | * CAMK2A | 1.04506956 |
| 44 | MAPK13 | 0.99517192 |
| 45 | PKN1 | 0.99068977 |
| 46 | EPHA3 | 0.95692479 |
| 47 | PKN2 | 0.95230156 |
| 48 | TRIM28 | 0.93895316 |
| 49 | PRKCG | 0.93534431 |
| 50 | PHKG2 | 0.93394398 |
| 51 | PHKG1 | 0.93394398 |
| 52 | * CAMK2B | 0.91009345 |
| 53 | LMTK2 | 0.89918230 |
| 54 | * CDK5 | 0.89074846 |
| 55 | PAK6 | 0.88250503 |
| 56 | LIMK1 | 0.88182286 |
| 57 | MAP3K13 | 0.85674710 |
| 58 | PAK3 | 0.84467042 |
| 59 | MAP3K2 | 0.81822737 |
| 60 | DYRK1A | 0.80473093 |
| 61 | * CDK14 | 0.80034911 |
| 62 | MAP3K1 | 0.77486763 |
| 63 | MAP3K11 | 0.75294992 |
| 64 | MAP2K1 | 0.75110661 |
| 65 | DYRK1B | 0.74758479 |
| 66 | DYRK3 | 0.73403013 |
| 67 | * CDK18 | 0.73173363 |
| 68 | BRAF | 0.72048011 |
| 69 | * CDK15 | 0.70489532 |
| 70 | TLK1 | 0.70421073 |
| 71 | PLK3 | 0.69409282 |
| 72 | MATK | 0.68710861 |
| 73 | CAMKK1 | 0.67506328 |
| 74 | SGK2 | 0.67251720 |
| 75 | DAPK2 | 0.64867019 |
| 76 | MARK2 | 0.64110237 |
| 77 | FES | 0.64043797 |
| 78 | ERBB4 | 0.63481212 |
| 79 | SIK2 | 0.63318355 |
| 80 | * CDK11A | 0.60591466 |
| 81 | SCYL2 | 0.60491794 |
| 82 | CAMKK2 | 0.58889288 |
| 83 | TESK1 | 0.58835899 |
| 84 | MAP3K5 | 0.58666412 |
| 85 | MYLK | 0.58279571 |
| 86 | FLT3 | 0.56368528 |
| 87 | CAMK1G | 0.55471395 |
| 88 | WNK1 | 0.55042235 |
| 89 | SIK3 | 0.51808042 |
| 90 | CAMK1D | 0.51059326 |
| 91 | FER | 0.50203187 |
| 92 | PRKAA1 | 0.49988381 |
| 93 | SGK494 | 0.49486288 |
| 94 | SGK223 | 0.49486288 |
| 95 | SYK | 0.46609327 |
| 96 | MOS | 0.45021313 |
| 97 | TAOK3 | 0.44455881 |
| 98 | HIPK2 | 0.43377089 |
| 99 | INSRR | 0.43323170 |
| 100 | CAMK4 | 0.43255526 |
| 101 | SGK1 | 0.43043296 |
| 102 | MAPK15 | 0.41958283 |
| 103 | DAPK1 | 0.41478909 |
| 104 | * PRKACA | 0.40695897 |
| 105 | STK16 | 0.39570856 |
| 106 | RPS6KA2 | 0.38739497 |
| 107 | KSR1 | 0.38334375 |
| 108 | CSNK1E | 0.36278332 |
| 109 | PRKCE | 0.36060618 |
| 110 | TYRO3 | 0.34757902 |
| 111 | PRKCH | 0.33448550 |
| 112 | CSNK1A1 | 0.32573225 |
| 113 | PRKG1 | 0.31074114 |
| 114 | CSNK1A1L | 0.29733197 |
| 115 | DDR2 | 0.29342878 |
| 116 | EPHA4 | 0.29243122 |
| 117 | FYN | 0.28984937 |
| 118 | IGF1R | 0.28921611 |
| 119 | PRKCB | 0.28625386 |
| 120 | * CAMK2D | 0.27403429 |
| 121 | EPHB2 | 0.26657120 |
| 122 | WNK3 | 0.26538089 |
| 123 | BCR | 0.25796828 |
| 124 | OXSR1 | 0.25701241 |
| 125 | GRK1 | 0.24427105 |
| 126 | ROCK2 | 0.24061039 |
| 127 | CDK8 | 0.23506371 |
| 128 | SRC | 0.23459505 |
| 129 | PRKCZ | 0.22933792 |
| 130 | RAF1 | 0.22787491 |
| 131 | * CAMK2G | 0.22417700 |
| 132 | NEK1 | 0.22163632 |
| 133 | PRKCA | 0.22044781 |
| 134 | MAPK8 | 0.21655549 |
| 135 | CSNK1D | 0.20689265 |
| 136 | RIPK4 | 0.20318622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.30297135 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.97314566 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.94618439 |
| 4 | * Cocaine addiction_Homo sapiens_hsa05030 | 3.79636199 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.15233607 |
| 6 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.83583263 |
| 7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.75122400 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.59560140 |
| 9 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.56714916 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.27794473 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27244386 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.25478039 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.20860812 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.11114908 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.06168433 |
| 16 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.99170132 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92124244 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.82386206 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.68986359 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.63596254 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.58080259 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56350751 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.53736657 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53572735 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47440714 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.47368588 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45977778 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.42484458 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37832678 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.34004037 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.31089036 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28620220 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26178304 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.25690053 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25032455 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23374463 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.22854114 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.20515396 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.19902253 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.14877076 |
| 41 | * Alcoholism_Homo sapiens_hsa05034 | 1.07703512 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05208739 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03935350 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00444968 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99005574 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97189595 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96977050 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96459237 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94908622 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93405610 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91188733 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88881455 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88112566 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85205767 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85129612 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.83858508 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82276277 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79762499 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.78379183 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75829227 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75634817 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75410067 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75103062 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70925677 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68809812 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68675552 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66037955 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64869997 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64306704 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64018339 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63629714 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61817105 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61643023 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59536233 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54459665 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53037629 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53026321 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52852119 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52800335 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.50190776 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49818981 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.49238055 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48505251 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48028683 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.47491409 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45944947 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44946242 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44563769 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43505722 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.43135559 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43084544 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42939285 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38719843 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38652262 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38307267 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37622466 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37389048 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37262156 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33936021 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32384238 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31602854 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30913118 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29487138 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29263199 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28199601 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27486770 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26212469 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25914814 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.25390214 |
| 110 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24510619 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23991482 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.21994845 |
| 113 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.21900464 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.21198542 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.20693161 |
| 116 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.19365354 |
| 117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19217974 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18062677 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.17019208 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.15885958 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.15727109 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15677448 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.15158276 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14153439 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.14094554 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13252286 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.11896848 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11286514 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.11155540 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.10003669 |

